Prostate Carcinoma — Trials

Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,176 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 428
Recruiting: 230
Ph III recruiting: 20
Growth YoY: −2.6%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (184)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05415228	Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer	no longer available	—	—	Morand Piert, MDOTHER	0	May 18, 2023	clinicaltrials
NCT04825652	177Lu-PSMA-617 Managed Access Program for mCRPC Patients	no longer available	—	—	Advanced Accelerator ApplicationsINDUSTRY	0	Jan 13, 2023	clinicaltrials